{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:00:53Z","timestamp":1780513253350,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtct.2025.12.1004","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:57:58Z","timestamp":1769187478000},"page":"584.e1-584.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia\/Lymphoma"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-817X","authenticated-orcid":false,"given":"Maria","family":"Klimentova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Shelikhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarite","family":"Perminova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Molostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Shasheleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dunaykina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Diakonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Daghestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Pershin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-6986","authenticated-orcid":false,"given":"Alexander","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Olshanskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Balashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Myakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0093","authenticated-orcid":false,"given":"Michael","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0001","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2009.22.2950","article-title":"Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia consortium study","volume":"28","author":"Ko","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.1004_bib0002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.22416","article-title":"Pediatric T-cell acute lymphoblastic leukemia","volume":"56","author":"Karrman","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.1004_bib0003","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.2022016772","article-title":"Avoiding fratricide: a T-ALL order","volume":"140","author":"Gower","year":"2022","journal-title":"Blood [Internet]"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-023-00822-w","article-title":"Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.1004_bib0006","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.bbmt.2012.07.011","article-title":"Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia","volume":"18","author":"Bakr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"10.1016\/j.jtct.2025.12.1004_bib0007","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/blood.V120.21.356.356","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation for adult patients with T-cell acute lymphoblastic leukemia: a survey from the acute leukemia working party of the European Group for blood and marrow transplantation (EBMT)","volume":"120","author":"Cahu","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.1004_bib0008","first-page":"84","article-title":"Features of relapses and refractory forms of T-lymphoblastic lymphoma in children","volume":"19","author":"Abashidze","year":"2020","journal-title":"Pediatr Hematol\/Oncol Immunopathol"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.782785","article-title":"Allogeneic hematopoietic stem cell transplantation for children with acute lymphoblastic leukemia: shifting indications in the era of immunotherapy","volume":"9","author":"Truong","year":"2021","journal-title":"Front Pediatr"},{"issue":"31","key":"10.1016\/j.jtct.2025.12.1004_bib0010","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-M\u00fcnster Group 87","volume":"23","author":"Einsiedel","year":"2005","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.1004_bib0011","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/CM9.0000000000001999","article-title":"Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission","volume":"135","author":"Zhang","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/bmt.2016.194","article-title":"Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes","volume":"52","author":"Brammer","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.1004_bib0013","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","article-title":"Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL","volume":"99","author":"Willemse","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V124.21.1.1","volume":"124","author":"Wood","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.1004_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1182\/blood.V114.22.324.324","article-title":"Successful subtype oriented treatment strategies in adult T-All; results of 744 patients treated in three consecutive GMALL studies","volume":"114","author":"Hoelzer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0017","article-title":"Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78334-x","article-title":"Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies","volume":"10","author":"Morita-Fujita","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.1004_bib0019","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/bjh.19481","article-title":"Allogeneic haematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: a real-world multicentre analysis in China","volume":"204","author":"Huo","year":"2024","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.1004_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.12722","article-title":"Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment","volume":"96","author":"Bassan","year":"2016","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.1004_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2024.100029","article-title":"T-cell lymphoblastic lymphoma compared with T-cell acute lymphoblastic leukemia: similar subtypes and different fusions","volume":"1","author":"Kroeze","year":"2024","journal-title":"Blood Neoplasia"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0022","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2010.10.003","article-title":"T-lineage lymphoblastic lymphoma and leukemia-a MASSive problem","volume":"18","author":"Mullighan","year":"2010","journal-title":"Cancer Cell"},{"issue":"Suppl 3","key":"10.1016\/j.jtct.2025.12.1004_bib0023","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.3816\/CLM.2009.s.015","article-title":"T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?","volume":"9","author":"Hoelzer","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"14","key":"10.1016\/j.jtct.2025.12.1004_bib0024","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1182\/bloodadvances.2020001822","article-title":"T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?","volume":"4","author":"Kroeze","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cyto.b.21518","article-title":"AIEOP-BFM Consensus Guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia","volume":"94","author":"Dworzak","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0026","doi-asserted-by":"crossref","first-page":"165","DOI":"10.24287\/1726-1708-2023-22-1-165-177","article-title":"Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies","volume":"22","author":"Popov","year":"2023","journal-title":"Pediatr Hematol\/Oncol Immunopathol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.1004_bib0027","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3390\/ijms26052002","article-title":"Analysis of antigen expression in T-cell acute lymphoblastic leukemia by multicolor flow cytometry: implications for the detection of measurable residual disease","volume":"26","author":"Semchenkova","year":"2025","journal-title":"Int J Mole Sci"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.24287\/1726-1708-2019-18-1-12-21","article-title":"First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia","volume":"18","author":"Dyakonova","year":"2019","journal-title":"Pediatr Hematol\/Oncol Immunopathol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.1004_bib0029","doi-asserted-by":"crossref","first-page":"127.e1","DOI":"10.1016\/j.jtct.2022.11.022","article-title":"Targeted therapy with venetoclax and daratumumab as part of HSCT Preparative regimen in children with chemorefractory acute myeloid leukemia","volume":"29","author":"Klimentova","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.1004_bib0030","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0031","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.1004_bib0032","doi-asserted-by":"crossref","first-page":"510.e1","DOI":"10.1016\/j.jtct.2023.05.006","article-title":"Acute Leukemia relapse after hematopoietic stem cell transplantation: the good, the bad, and the ugly of isolated extramedullary relapse in a latin american population","volume":"29","author":"Arias-Espinosa","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0033","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","article-title":"Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia","volume":"56","author":"Greil","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0034","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcyt.2024.11.016","article-title":"Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Espa\u00f1ol de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee","volume":"27","author":"Gonz\u00e1lez Vicent","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0035","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.287456","article-title":"Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial","author":"Balduzzi","year":"2025","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.1004_bib0036","doi-asserted-by":"crossref","first-page":"510.e1","DOI":"10.1016\/j.jtct.2023.05.006","article-title":"Acute leukemia relapse after hematopoietic stem cell transplantation: the good, the bad, and the ugly of isolated extramedullary relapse in a Latin American Population","volume":"29","author":"Arias-Espinosa","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.1004_bib0037","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbmt.2017.03.023","article-title":"Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse","volume":"23","author":"Shem-Tov","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0038","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3324\/haematol.2019.237230","article-title":"Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group phase III study AALL0433","volume":"106","author":"Lew","year":"2021","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.1004_bib0039","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bbmt.2015.08.023","article-title":"Transplant outcomes for children with T cell acute lymphoblastic leukemia in second remission: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Burke","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"15","key":"10.1016\/j.jtct.2025.12.1004_bib0040","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.2022018653","article-title":"Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children\u2019s Oncology Group report","volume":"141","author":"Gossai","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1191912","article-title":"Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia","volume":"14","author":"Hodroj","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2025.12.1004_bib0042","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41409-023-01948-y","article-title":"Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia","volume":"58","author":"Fan","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3324\/haematol.2019.219790","article-title":"Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT","volume":"105","author":"Dholaria","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.1004_bib0044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41409-023-02137-7","article-title":"Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study","volume":"59","author":"Yang","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.1004_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1705024","article-title":"Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study","volume":"36","author":"Choi","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.1004_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27950","article-title":"Single center experience suggests donor lymphocyte infusion may promote long-term survival in children with high-risk acute lymphoblastic leukemia","volume":"66","author":"Liberio","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2025.12.1004_bib0047","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1182\/blood-2024-211122","article-title":"Early immune reconstitution post allogeneic transplant and its impact on outcomes according to type of transplant","volume":"144","author":"Saha","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0048","doi-asserted-by":"crossref","first-page":"435.e1","DOI":"10.1016\/j.jtct.2024.01.070","article-title":"Impact of natural killer cell-associated factors on acute leukemia outcomes after haploidentical hematopoietic stem cell transplantation with \u03b1\u03b2 T cell depletion in a pediatric cohort","volume":"30","author":"Glushkova","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.1004_bib0049","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005031","article-title":"Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"13","author":"Mushtaq","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.1004_bib0051","first-page":"174","article-title":"The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation","volume":"10","author":"Fedele","year":"2012","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.jtct.2025.12.1004_bib0052","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jcyt.2025.07.005","article-title":"Very early recovery of T cells after alpha\/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia","volume":"27","author":"Glushkova","year":"2025","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.1004_bib0053","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.1004_bib0054","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.1004_bib0055","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.1004_bib0056","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/bloodadvances.2022009376","article-title":"CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia","volume":"7","author":"Akahoshi","year":"2023","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0057","doi-asserted-by":"crossref","DOI":"10.46989\/001c.125912","article-title":"Role of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia","volume":"6","author":"Mekni","year":"2024","journal-title":"Clin Hematol Int"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.1004_bib0058","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2003.11.002","article-title":"Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia","volume":"10","author":"Nordlander","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2025.12.1004_bib0059","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","article-title":"Antileukemic effect of chronic graft-versus-host disease","volume":"304","author":"Weiden","year":"1981","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/bloodadvances.2018027003","article-title":"The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia","volume":"3","author":"Yeshurun","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.1004_bib0061","doi-asserted-by":"crossref","first-page":"330.e1","DOI":"10.1016\/j.jtct.2021.01.010","article-title":"Serotherapy-free regimen improves non-relapse mortality and immune recovery among the recipients of \u03b1\u03b2 TCell\u2013depleted haploidentical grafts: retrospective study in childhood leukemia","volume":"27","author":"Shelikhova","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.1004_bib0062","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41409-021-01232-x","article-title":"Safety and efficacy of the low-dose memory (CD45RA-depleted) donor lymphocyte infusion in recipients of \u03b1\u03b2 T cell-depleted haploidentical grafts: results of a prospective randomized trial in high-risk childhood leukemia","volume":"56","author":"Dunaikina","year":"2021","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:09:51Z","timestamp":1780312191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666636726000011"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.1004","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children with T Cell Acute Lymphoblastic Leukemia\/Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.1004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}